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Abstract
Background: The prevalence of asthma and other allergic diseases among children living in Eastern is not well
described. Our objective was to estimate and compare the prevalence of asthma, respiratory symptoms and
allergic diseases in children in Belarus, Ukraine, and Poland as well as to identify risk factors for these conditions. We
also sought to profile and compare children with asthma between locations.
Methods: Data were collected as a part of an international, multicenter, cross-sectional study of childhood asthma: The
Belarus Ukraine Poland Asthma Study (BUPAS). Subjects were children aged 7–13 years attending primary and secondary
schools in the urban and surrounding rural area of Grodno (Belarus), Ternopil (Ukraine) and Silesia Region (Poland).
Physician-diagnosed respiratory diseases and symptoms as well as allergic diseases were ascertained using the ISAAC
questionnaire completed by the parents.
Results: In total there were 4019 children from Belarus (rural: 2018, urban: 2001), 4493 from Ukraine (1972; 2521),
and 4036 from Poland (2002, 2034). The overall response rate was 76.7 %. Groups were similar in case of gender
and age (p > 0.05). Almost all analyzed respiratory and allergic conditions differed significantly between countries
including asthma [Poland (rural, urban): 3.5 %, 4.1 %; Ukraine: 1.4 %, 2.1 %; Belarus: 1.4 %, 1.5 %], spastic bronchitis
(Poland: 2.7 %, 3.2 %; Ukraine: 7.5 %, 6.5 %; Belarus: 6.4 %, 7.9 %), and chest wheeze in the last year (Poland: 4.8 %,
5.2 %; Ukraine: 11.5 %, 13.0 %; Belarus: 10.7 %, 10.0 %). These differences remained after adjustment for potential
confounders. Risk factor associations were generally similar between outcomes. Symptom characteristics of children with
asthma between countries were not consistent. The ratio of current wheeze:diagnosis of asthma differed by country:
(Rural areas: Belarus: 10.9:1, Ukraine: 17.3:1, Poland: 2.4:1; Urban areas: Belarus: 8.1:1, Ukraine: 7.3:1 Poland: 1.9:1).
Conclusions: The findings show large between-country differences and relatively low prevalence of asthma and allergic
diseases in children of Western Belarus and Ukraine. There is evidence for underdiagnosis of asthma in these regions.
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Background
Geographic variation in childhood asthma prevalence has
been reported [1, 2] with the global prevalence of asthma
and related symptoms has ranged between approximately
2 and 37 % [1]. One difficulty in assessing asthma preva-
lence is potential differential use of labels for asthma. As
such, it is important to symptoms, which do not require a
diagnostic label and alternate labels for asthma and the
potential of differences in asthma prevalence due to label-
ing differences.
While some investigation of asthma prevalence has been
completed in Eastern Europe, including a regional investi-
gation of countries from Eastern and Central Europe [3]
which showed between-country variation in prevalence
was more dominant than within-country variation along
with some indication of diagnostic labeling explaining dif-
ferences by region, there has been very little work com-
pleted in countries outside the EU including Ukraine and
Belarus. Previously, we have described investigations of
asthma prevalence separately in Ukraine [4] and Belarus
[5] as part of the Belarus, Ukraine, and Poland Asthma
Study (BUPAS). In each of these locations, there was some
evidence of asthma underdiagnosis [4, 5] Qualitatively, the
prevalence of asthma was lower in these countries com-
pared to Western European nations, with possible underdi-
agnosis occurring. These observations, along with societal
changes towards a Westernized lifestyle, which has been
associated with higher asthma prevalence, make it likely
that the prevalence of asthma will increase in the future.
Indeed, we have some evidence suggesting increases of
asthma prevalence in Eastern Europe [6]. Thus, asthma
may be poised to increase as a public health problem in
this region. Identification of reasons for geographic differ-
ences and risk factors for asthma, including consistency be-
tween regions, in these locations will help develop our
etiologic understanding of asthma and may help our future
management strategies for children with lung disease.
We further our previous work of BUPAS countries by
combining the data from each country, which were based
on data collection using the same questionnaires and
study design. Specifically, we sought to: 1) compare preva-
lence of diagnosed asthma, diagnosed spastic bronchitis,
respiratory symptoms, and allergic disorders between the
three BUPAS countries; 2) To compare the prevalence
and strength of association of risk factors for diagnosed
asthma, wheeze, and spastic bronchitis between the three
BUPAS countries; 3) To analyze the magnitude of urban–
rural differences in the occurrence of diagnosed asthma in
the three BUPAS countries; and 4) To compare symptoms
profiles of children with diagnosed asthma between the
three BUPAS countries. While we have previously de-
scribed asthma prevalence and its determinants in Belarus
and Ukraine as part of the BUPAS program, [4, 5] we have
expanded on our previous investigations. First, the focus
of the current paper is on between country differences,
which allow us to make quantitative comparisons between
regions. Second, this will be the first time where results
from the Polish data are presented. Third, while minor, we
focus on a slightly narrower age range than the previous
studies in order to be able to include comparative data
from all countries.
Methods
Study design and study population
Data were collected as a part of an international, multicen-
ter, cross-sectional study of childhood asthma: The Belarus
Ukraine Poland Asthma Study (BUPAS). Subjects were
children aged 7–13 years attending primary and secondary
schools in the urban and surrounding rural area of Ternopil
(Ukraine), Grodno (Belarus) and Katowice (Poland). This
age group was chosen given that this is generally when
asthma prevalence is highest, it allows reasonable responses
based on proxy report (i.e., parents), and for comparison, is
comparable to ages consistently considered in other studies
evaluating asthma prevalence in childhood. Schools were
randomly selected from the urban center and the rural re-
gion, which included villages where agricultural activity was
the primary industry, surrounding each urban area from
which 3000 urban children and 3000 rural children were
approached. This included 36 schools from urban areas in
Belarus (10), Ukraine (11), and Poland (15) and 79 schools
from rural areas in Belarus (20), Ukraine (23), and Poland
(36). The number of schools included in each region differ
due to differences in the number of students attending each
school as participation rates were similar. Children from se-
lected schools and their parents or legal guardians were
invited to participate in the project. Questionnaires, accom-
panied by a letter explaining the study objectives and an
informed written consent, were distributed to parents/
guardians through the schools. Upon completion of the
questionnaire, they were returned to the school where they
were picked up by the research team. The study protocol
was approved by the adequate local ethics committees at
the State Medical University of Ternopil (Ukraine), Yanka
Kupala University in Grodno (Belarus) and Medical Univer-
sity of Silesia in Katowice (Poland). None of the authors
have any competing interests related to this manuscript.
Study instrument and operational definitions
The questionnaire included standard questions from the
International Study of Asthma and Allergy in Children
(ISAAC) respiratory questionnaire [2, 7] All questions
were translated from English to Ukrainian, Russian and
Polish respectively and their syntax was verified by back-
translation. The ISAAC questionnaire has been used inter-
nationally and validated in many languages [8]. ISAAC
questions have been used in Polish and Russian speaking
populations previously [8]. The questionnaire included
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questions about established respiratory and allergic diagno-
ses, respiratory and allergic symptoms, family history of re-
spiratory and allergic disorders, and socio-economic status.
Location of dwelling was classified as urban or rural based
on whether the child lived in the city (Grodno, Ternopil,
Katowice) or the surrounding agricultural area. This was
accounted for by targeting schools in these regions.
The list of analyzed allergic and respiratory diseases in-
cluded diagnoses established during the child’s lifetime by
a physician and reported by subjects’ parents for asthma
and spastic bronchitis. Spastic bronchitis is a traditional
diagnosis of the region and is used to describe chronic or
recurrent asthmatic symptoms such as “wheezy bron-
chitis”. Respiratory symptoms in the past 12 months were
also assessed by report on the questionnaire.
Several variables were considered as potential corre-
lates of respiratory outcomes. Parental asthma, allergic
rhinitis, eczema were separately defined by a report of a
positive history of physician diagnosed disease by either
the mother or father. Current smoking and highest level
of education were obtained for each of the mother and
the father. Exposure to tobacco smoke was present when
at least one family member smoked at home. Additional
exposures were assessed by responses on the question-
naire based on the presence or absence of these exposures
and included using coal or wood for cooking or heating,
smoking during pregnancy, passive smoking during preg-
nancy, the presence of dog and cat in the home, and
dampness at home. Evaluation of health care utilization
and morbidity was based on answers to questions regard-
ing medication use for breathing, specialist or general
practitioner visits for breathing conditions, completion of
spirometry testing, and completion of skin prick testing,
all in the past 12 months.
Height (cm) and weight (kg) were reported on the ques-
tionnaire. From these measures, body mass index (BMI)
was calculated based on the equation: [BMI =weight (kg)/
height (m)2] [9]. Weight status was classified based on
categorization of body mass index (BMI) using values de-
scribed by Cole et al. [10] which base the cutoff value as
the predicted adult (at 18 years of age) equivalent of a
BMI of 25 for overweight and of 30 for obese.
Statistical analysis
All analyses were completed using SPSS 20. Statistical sig-
nificance was defined by an alpha level of 0.05. Continuous
variables were described by arithmetic mean values and
standard deviations. Categorical variables were described
by frequencies and proportions. Descriptive and compara-
tive analyses were completed after stratification by urban/
rural status because of the method of sampling. Statistical
significance of between-group differences in mean values
was assessed by t-test and ANOVA, or nonparametric tests
when distribution was not normal. When using categorical
variables statistical significance was assessed by means of
the independent samples chi-squared test. Initially, com-
parisons of personal and environmental factors were made
between locations and between urban and rural status for
each location. Following this analysis, comparisons of con-
dition and symptom prevalence were made between loca-
tions and between urban and rural status for each location.
Multiple logistic regression was then completed to in-
vestigate the association between report of diagnosed
asthma, diagnosed spastic bronchitis, and wheeze in the
past 12 months with location and urban/rural status after
adjusting for potential confounders. A multiple logistic
model was fitted for each health outcome independently.
Potential confounders were included based on their previ-
ously reported associations with asthma and availability
on the questionnaire. For each model, the same fixed set
of independent variables was tested to examine their asso-
ciation with the dependent variable and to control for po-
tential confounding: age, sex, parental education, parental
history of allergic disease, exposure to tobacco smoke at
home, mother smoking during pregnancy, location of
dwelling (urban or rural), use of coal or wood for cooking
or heating, dampness, and dog or cat at home. The
strength of the associations between the independent and
dependent variables were quantified by odds ratios and
their 95 % confidence intervals (CI). Statistical inference
was based on the criterion p < 0.05. Interaction between
location and each of the personal and environmental fac-
tors was tested using the Likelihood ratio test to assess if
associations were consistent between locations. These re-
sults were also presented by stratified analyses.
Finally, among children with a previous diagnosis of
asthma, we compared indicators of asthma severity and
morbidity including hospitalization for asthma, visiting a
physician for asthma, assessment by spirometry, assess-
ment by skin prick testing and the presence of asthma-
related symptoms between locations. This was completed
using independent samples chi-squared tests.
Results
In total there were 4019 children from Belarus (rural:
2018, urban: 2001), 4493 children from Ukraine (rural:
1972, urban: 2521), and 4036 children from Poland (rural:
2002, urban: 2034). The response rate was 79.2 % in
Ukraine, 77.8 % in Belarus and 75.4 % in Poland and was
similar (>0.05) between urban and rural areas from each
region. When comparing differences in the frequency of
personal and environmental characteristics between coun-
tries (Table 1), there were many statistically significant dif-
ferences. Among urban and rural dwellers, there were
differences between countries for mother’s and father’s
education levels, parental history of allergic disease, paren-
tal smoking, maternal smoking during pregnancy, use of
coal or wood for cooking or heating, presence of mold or
Brozek et al. BMC Pulmonary Medicine  (2016) 16:11 Page 3 of 11
dampness, and presence of a cat or dog. However, the dif-
ferences were not always consistent in direction or magni-
tude. In addition to this, a lower proportion of urban
dwelling children from Belarus were female compared to
urban children from Ukraine or Poland and urban dwell-
ing children from Ukraine were older than urban children
from Belarus or Poland (Table 1).
The prevalence of asthma differed significantly by coun-
try for both urban and rural dwellers with the highest
prevalence consistently in Poland (Rural: 3.5 %, Urban:
4.1 %) followed by Ukraine (Rural: 1.4 %, Urban: 2.1 %)
and Belarus (Rural: 1.4 %, Urban: 1.5 %). The difference
was not statistically significant between urban and rural
dwellers in any country. Almost all other respiratory and
allergic conditions considered differed significantly be-
tween countries for both urban and rural dwellers (Table 2).
Similar to asthma, a higher prevalence of allergic condi-
tions and symptoms, with the exception of eczema or skin
allergy, was found in Poland compared to Ukraine and
Belarus. While differences between countries were statisti-
cally significant, the direction of the differences was not en-
tirely consistent when comparing respiratory symptoms.
However, diagnosis of spastic bronchitis was consistently
lower in Poland compared to Belarus and Ukraine.
Table 3 presents the findings from adjusted analyses for
report of diagnosed asthma (primary interest), wheeze in
the past 12 months (symptom reflective of asthma), and
diagnosed spastic bronchitis (a diagnostic label thought to
be used in place of asthma in the region). Compared to
Belarus, children in Poland were at a higher risk of diag-
nosed asthma but a lower risk of wheeze in the past
12 months and spastic bronchitis while children from
Ukraine were at increased risk of wheeze in the past
12 months. Females were at lower risk of any of the three
outcomes with similar strengths of associations. There was
a consistent increased risk of any of the three outcomes
with the presence of parental history of allergic disease and
mold or dampness in the home. Maternal smoking during
pregnancy increased the risk of asthma and spastic bron-
chitis but this was only statistically significant for asthma.
While having a dog was inversely associated with all three
outcomes, it was only statistically significant for spastic
bronchitis. Finally, increasing age was associated with an
increased risk of diagnosed asthma but a reduced risk of
wheeze in the past 12 months and spastic bronchitis.
We assessed the presence of interaction between country
and the personal and environmental variables. When con-
sidering asthma as the outcome, there was statistically sig-
nificant interaction between country and sex (p = 0.03) as
well as home mold or dampness (p = 0.04). When consider-
ing wheeze in the past 12 months as the outcome, there
was statistically significant interaction between country and
home mold or dampness as well as age (p < 0.001). When
considering spastic bronchitis there was statistically signifi-
cant interaction between parental history of allergic disease
(p = 0.004) as well as home mold or dampness (p = 0.002).
Because of these results, we reran the adjusted analysis after
stratification by country and presented the results for the














% Female 47.4 50.9 50.9** 49.8 51.5 51.8
% Mother with > high school 46.9* 54.1* 19.2*, ** 19.7 41.9 13.0***
% Father with > high school 38.8* 45.7* 13.4*, ** 16.3 32.0 6.8
***
Obesity status
% Not overweight or obese 87.1 87.8 86.8 88.3 85.9 88.2
% Overweight 11.5 10.7 11.8 10.0 11.2 10.4
% Obese 1.4 1.5* 1.5 1.7 3.0 1.5***
% Any parental history of allergic disease 14.7* 11.7* 30.7*, ** 8.8 8.0 20.0***
% Either parent currently smoking 50.1* 50.9 46.5*, ** 57.8 53.4 43.0***
% Maternal smoking during pregnancy 2.5 0.9 7.0*, ** 2.4 1.1 4.4***
% Using coal or wood for cooking or heating 4.8* 1.4* 10.6*, ** 28.3 6.8 28.2***
% Any mold or dampness in the home 30.5 47.9* 34.2*, ** 29.9 55.8 27.5***
% With a cat 34.6* 27.9* 34.4*, ** 61.4 64.2 43.9***
% With a dog 23.7* 17.2* 50.2*, ** 45.6 54.2 55.1***
Mean age, years (SD) 10.2 (1.9) 10.4 (1.9)* 10.2 (1.9)** 10.2 (1.9) 10.2 (1.9) 10.3 (1.9)
*p < 0.05 comparing urban to rural within country
**p < 0.05 comparing across countries among urban children
***p < 0.05 comparing across countries among rural children
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interaction variables in Fig. 1. In general, we found similar
associations in Belarus and Poland and weaker, non-
statistically significant associations within Ukraine.
Finally, we profiled the clinical characteristics of chil-
dren with asthma and compared these by rural–urban
status and by country (Table 4). When comparing char-
acteristics of children with asthma by country, among
rural dwellers, there were differences by country for
diagnosis of rhinitis, rhinitis symptoms, taking breathing
medication in the past 12 months, using asthma medica-
tion in the past 12 months, and being hospitalized for
breathing troubles in the past 12 months (Table 4).
Among urban children with asthma, differences by country
existed for diagnosis of spastic bronchitis, diagnosis of
rhinitis, diagnosis of any allergy, ever had a skin allergy or
itching, using asthma medication in the past 12 months,
being hospitalized for breathing troubles in the past
12 months, and having spirometry testing in the past
12 months (Table 4). Finally, to further consider some is-
sues that may be related to diagnosis, we calculated the
proportion of children with wheeze in the past 12 months
who had a diagnosis of asthma. Belarus and Ukraine had
lower proportions of those with wheeze in the past
12 months having an asthma diagnosis than in Poland for
both rural (Belarus: 8.4 %, Ukraine: 5.5 %, Poland: 29.0 %)
and urban regions (Belarus: 10.9 %, Ukraine: 12.1 %,
Poland: 34.7 %). Related to these results, we considered the
ratio of (current wheeze):(previous diagnosis of asthma). In
rural areas this ratio was 10.9:1 in Belarus, 17.3:1 in
Ukraine, and 2.4:1 in Poland. Similar patterns were ob-
served in the urban areas (Belarus: 8.1:1, Ukraine: 7.3:1
Poland: 1.9:1).
In general, urban children with a report of doctor di-
agnosed asthma had a higher prevalence of conditions
present than rural children. In Belarus we found urban
children with a report of doctor diagnosed asthma to
have a higher proportion of spastic bronchitis and aller-
gic conditions or symptoms. In Ukraine, urban children
with a report of doctor diagnosed asthma had a higher
prevalence of wheeze in the past 12 months and cough
in the past 12 months. In Poland, urban children with a
report of doctor diagnosed asthma had a higher preva-
lence of asthma attacks in the past 12 months, had been
woken by asthma attacks in the past 3 months, and had
nocturnal shortness of breath in the past 12 months.
Discussion
While asthma prevalence was higher in Poland com-
pared to Belarus and Ukraine, spastic bronchitis diag-
nosis, an alternative to asthma diagnosis in some
countries, was higher in Belarus and Ukraine compared
to Poland. While chest wheeze in the past 12 months
was lower in Poland than in the other two countries
and report of diagnosed rhinitis and rhinitis symptoms














Ever diagnosed with asthma 1.5 2.1 4.1† 1.4 1.4 3.5***
Asthma attacks in the past 12 months 0.7 0.9 1.8** 0.7 0.7 1.2
Woken by asthma attacks in the past 3 months 0.5 0.4 1.4*, ** 0.3 0.7 0.7
Spastic bronchitis 7.9 6.5 3.2** 6.4 7.5 2.7***
Ever had chest wheeze 10.2 32.9* 14.7*, ** 10.7 30.0 11.9***
Chest wheeze in the past 12 months 10.0 13.0 5.2** 10.7 11.5 4.8***
SOB with exercise in the past 12 months 4.0 6.6 4.7*, ** 3.6 5.8 3.1***
Nocturnal SOB in the past 12 months 1.7* 1.8 3.5*, ** 1.0 1.7 2.2***
Cough in the past 12 months 58.4* 73.4* 68.8** 65.1 70.5 67.8***
Productive cough in the past 12 months 34.0* 46.0 52.5*, ** 39.4 44.3 42.8***
Ever diagnosed with rhinitis 5.3* 3.6 22.8*, ** 2.1 4.4 14.7***
Ever diagnosed with eczema 12.6* 7.0 12.7*, ** 8.6 6.8 7.4
Ever diagnosed with any allergy 17.7* 12.0 24.3*, ** 10.7 13.1 16.1***
Ever had symptoms of allergic rhinitis or hayfever 3.7* 7.9* 20.6*, ** 1.1 4.7 14.2***
Ever had sneezing with congestion or intense
runny nose apart from a cold
10.0* 14.3* 21.1*, ** 7.0 9.7 13.6***
Ever had skin allergy or itching 15.3* 14.1* 11.2*, ** 12.7 11.7* 7.1***
*p < 0.05 comparing urban to rural within country
**p < 0.05 comparing across countries among urban children
***p < 0.05 comparing across countries among rural children
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were higher in Poland, there were inconsistent patterns
in symptom prevalence. With the exception of the
country of residence and its association with the out-
comes considered, the associations between suspected
asthma risk factors and asthma were generally consist-
ent between locations where there was an increased
risk of asthma associated with parental history of al-
lergy and presence of home mold or dampness along
Table 3 Adjusted a associations between respiratory health risk factors and outcomes of report of diagnosed asthma, wheeze in the
past 12 months, and diagnosed spastic bronchitis
Diagnosed asthma
OR (95 % CI)
Wheeze in the past 12 months
OR (95 % CI)
Diagnosed spastic bronchitis
OR (95 % CI)
Country
Belarus 1.00 1.00 1.00
Ukraine 1.32 (0.86–2.01) 1.20 (1.02–1.43) 0.99 (0.81–1.24)
Poland 2.40 (1.67–3.44) 0.42 (0.34–0.51) 0.36 (0.28–0.47)
Sex
Male 1.00 1.00 1.00
Female 0.70 (0.53–0.92) 0.81 (0.70–0.94) 0.76 (0.64–0.91)
Mother with > high school
No 1.00 1.00 1.00
Yes 1.15 (0.81–1.65) 0.91 (0.77–1.09) 1.09 (0.88–1.36)
Father with > high school
No 1.00 1.00 1.00
Yes 0.93 (0.62–1.38) 1.06 (0.88–1.27) 1.11 (0.88–1.39)
Any parental history of allergic disease
No 1.00 1.00 1.00
Yes 3.01 (2.25–4.04) 1.62 (1.34–1.96) 2.72 (2.20–3.36)
Either parent currently smoking
No 1.00 1.00 1.00
Yes 1.18 (0.89–1.57) 1.03 (0.89–1.19) 0.95 (0.79–1.15)
Maternal smoking during pregnancy
No 1.00 1.00 1.00
Yes 2.42 (1.42–4.11) 0.98 (0.61–1.56) 1.50 (0.90–2.53)
Using coal or wood for cooking or heating
No 1.00 1.00 1.00
Yes 1.01 (0.67–1.51) 1.02 (0.80–1.29) 1.01 (0.75–1.31)
Any mold or dampness in the home
No 1.00 1.00 1.00
Yes 1.33 (1.01–1.77) 1.35 (1.16–1.56) 1.28 (1.07–1.55)
With a cat
No 1.00 1.00 1.00
Yes 0.84 (0.62–1.15) 0.93 (0.79–1.09) 1.04 (0.85–1.27)
With a dog
No 1.00 1.00 1.00
Yes 0.78 (0.57–1.06) 0.94 (0.80–1.11) 0.77 (0.62–0.96)
Residence
Rural 1.00 1.00 1.00
Urban 0.95 (0.71–1.27) 0.97 (0.83–1.13) 0.98 (0.80–1.19)
Age 1.11 (1.03–1.20) 0.93 (0.90–0.97) 0.95 (0.90–0.99)
aAdjusted for each variable in the table
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with an inverse association with sex. Our results sug-
gest that differences in diagnostic labeling may be oc-
curring. Symptom characteristics of children who had a
report of a diagnosis of asthma between countries were
not consistent. In light of this, it is important to further
examine regional variation in diagnostic labeling and
management practices among children with asthma as
well as those without asthma but with conditions labels
which may be used in place of asthma.
Our findings confirm those of global and regional in-
vestigations of childhood asthma prevalence where geo-
graphic variation has been observed [1–3, 11]. Generally,
Westernized nations have experienced a higher preva-
lence of asthma than non-Westernized nations. While
global differences have been relatively clear based on the
ISAAC studies, more regionally, within Europe, differ-
ences have also been shown to exist. One previous study
following ISAAC protocols found that there was higher
Fig. 1 Adjusted associations between personal and environmental characteristics with report of diagnosed asthma, diagnosed spastic bronchitis,
and wheeze in the past 12 months. a Outcome is report of diagnosed asthma. b Outcome is report of diagnosed spastic bronchitis. c Outcome is
report of wheeze in the past 12 months. All analyses are adjusted for sex, age, mother’s education level, father’s education level, parental history
of allergic disease, current parental smoking, maternal smoking during pregnancy, coal or wood use for cooking or heating, mold or dampness in
the home, cat in the home, dog in the home, and location of dwelling after stratification by country
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wheeze prevalence in Scandinavian centres compared to
Eastern European centers [11]. In addition to this, there
was a gradient where the highest prevalence was observed
in Scandinavia (Sweden and Finland; 11–19 %) followed
by Estonia, Latvia, and Poland (7.5–8.5 %), countries with
increasingly Westernized culture, and lowest in Albania,
Romania, Russia, Georgia, and Uzbekistan (2.6–5.9 %),
countries with the least amount of Western influence [11].
In a separate study of Eastern and Central Europe, similar
patterns of asthma prevalence were observed with a high
between-country variation but lower within-country vari-
ation in asthma prevalence [3]. However, from this study,
it was suggested that diagnostic differences may explain
some of the differences in asthma prevalence with bron-
chitis being used as a label more frequently in these cen-
tres compared to Western centres [3]. In our study, we
advance this concept by showing that even within rela-
tively close geographic proximity, these labeling differ-
ences occur where we see increased risk of asthma in
Poland but a significant inverse association with spastic
bronchitis in Poland.
Regardless of the outcome considered (asthma, wheeze
in the past 12 months, or spastic bronchitis), consistent
associations were observed personal and genetic factors.
A parental history of allergic disease suggests a strong
genetic component, which is well known to occur in
asthma and allergic disease [12, 13]. Given that wheeze
and spastic bronchitis are not thought to be as linked to
allergic disease and family history as asthma, this pro-
vides some evidence that there may be some labelling is-
sues, especially among those with spastic bronchitis
given the similarity in odds ratio with asthma (2.72 vs.
3.01, respectively).
Associations between the environment and asthma have
been less consistent. With regard to home mold or damp-
ness, each association was statistically significant with a
similar strength of association (odds ratios = 1.28–1.35).
Mold and dampness has been associated with asthma and
wheeze fairly consistently in recent years [14, 15]. While
having a dog showed a consistent inverse association with
each of the three outcomes considered, it was only statisti-
cally significant with spastic bronchitis and a trend to-
wards statistical significance with asthma. However, the
strength of each of these associations was almost identical
(odds ratios = 0.78 vs 0.77). With the similarity in associa-
tions, it again adds some evidence that some children with
Table 4 Distribution of symptoms, allergic conditions, health care utilization, and morbidity by country and location of residence














Asthma attacks in the past 12 months 50.0 42.3 42.7* 51.7 37.0 26.9
Woken by asthma attacks in the past 3 months 33.3 16.3 35.5* 24.1 17.4 16.9
Ever diagnosed with spastic bronchitis 76.7* 58.3 38.1** 48.3 53.8 37.9
Chest wheeze in the past 12 months 73.3 70.4* 45.5 62.1 44.4 40.9
SOB with exercise in the past 12 months 46.7 53.7 36.6 37.9 44.4 24.6
Nocturnal SOB in the past 12 months 30.0 23.1 37.3* 24.1 29.6 22.4
Cough in the past 12 months 83.3 90.7* 92.7 86.2 74.1 88.1
Productive cough in the past 12 months 80.0 70.0 67.1 58.6 63.0 62.5
Ever diagnosed with rhinitis 43.3* 31.9 76.0*, ** 13.8 25.0 55.9***
Ever diagnosed with eczema 56.7* 30.6 37.1 10.3 37.5 24.6
Ever diagnosed with any allergy 80.0* 46.0 66.2** 41.4 68.0 49.3
Ever had symptoms of allergic rhinitis or hayfever 50.0* 49.1 61.4 13.8 60.0 48.5‡
Ever had sneezing with congestion or intense runny nose apart
from a cold
76.7 66.7 65.1 62.1 77.8 55.2
Ever had skin allergy or itching 50.0 23.1 28.6** 37.9 44.4 21.7
Ever used medication for asthma 86.7 42.0 65.8** 93.1 55.6 60.3***
Hospitalization due to breathing troubles in the past 12 months 20.0 28.8 6.0** 20.7 20.0 4.8***
Visited a doctor for breathing troubles in the past 12 months 60.0 45.3 50.6 51.7 55.6 41.2
Spirometry testing in the past 12 months 43.3 16.7 26.2** 24.1 18.5 37.1
Skin prick testing in the past 12 months 30.0 20.4 22.6 20.7 18.5 31.4
*p < 0.05 comparing urban to rural within country
**p < 0.05 comparing across countries among urban children
***p < 0.05 comparing across countries among rural children
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spastic bronchitis may truly be children with asthma. Sev-
eral other studies have reported a protective effect. How-
ever, these associations are not consistent and can be
complex, often depending on other factors, and timing of
exposure.
There was also an inverse association between age with
wheeze in the past 12 months and age with ever diagnosed
with spastic bronchitis. This association is easily explain-
able for wheeze in the past 12 months since a high pro-
portion of children have wheeze while they are young but
will grow out of this transient wheeze later in life. It is a
little more difficult to explain the inverse association with
spastic bronchitis. Given that the prevalence of this out-
come is a cumulative indicator (ever diagnosed), we would
expect that the risk of having this diagnosis would in-
crease with age. Speculatively, it could be that the true
prevalence of asthma is increasing but there is mislabel-
ling where those with asthma are being labelled with spas-
tic bronchitis. In younger children, there will be more
labeling than had occurred with older children, leading to
an inverse association.
The consistency between countries in the relationship
between the various exposures and outcomes was encour-
aging and adds strength to our study. However, we did
find that some of the associations were dependent on
country. In general, while the associations were relatively
consistent, results from the Ukraine were weaker and not
statistically significant. A notable and consistent exception
was that of home mold or dampness which showed sig-
nificant effect modification with country regardless of out-
come. In each case, associations in Belarus and Poland
showed statistically significant increased risk while in
Ukraine, non-significant inverse associations were ob-
served. In a previous Canadian study, similar differences
in effect were observed between two south Saskatchewan
regions when considering mold and dampness [16]. While
interesting, some caution must be taken since the results
in Ukraine were weak and not statistically significant for
this variable. However, differences in the housing or en-
vironment may be leading to different types of mould
exposure, either in quantity or diversity, which may
then be leading to differential associations with the out-
comes. Those dwelling in Ukraine were much more
likely to report home mold or dampness in the home
compared to those in Belarus or Poland. A more rigor-
ous investigation with objective measures would help
explain these observations.
One of our research foci was to examine the association
between rural living and asthma. We did not find statisti-
cally significant associations between rural residence and
any of the considered outcomes. While not entirely consist-
ent, previous research has suggested less asthma prevalence
in rural areas compared to urban areas [17, 18] In our
multivariate analyses we did not observe this association
with asthma, wheeze in the past 12 months, or spastic
bronchitis. In previous studies, farm dwelling has gen-
erally showed a stronger, more consistent, association
with asthma than the more general rural dwelling. It may
be that in our analyses, we did not capture the environ-
mental effect associated with asthma through our defin-
ition of rural. Despite this, we found many differences in
environmental exposures between urban and rural dwellers
within each country and that based on crude analyses, the
prevalence of diagnosed allergic disease and symptoms
(e.g., eczema, rhinitis, general allergy) were almost always
significantly higher in urban compared to rural dwellers,
regardless of country. This is consistent with the existing
literature which has shown more consistent associations
with allergic disease than with asthma.
When we considered symptom characteristics among
those with asthma by country, few consistent patterns
emerged. One difficulty was that our statistical power in
this phase of the analysis was greatly reduced. Despite this,
among children with asthma, those living in Poland con-
sistently had a lower likelihood of being diagnosed with
spastic bronchitis or being hospitalized due to breathing
problems but an increased risk of having ever been diag-
nosed with rhinitis. These differences may be related to
better identification and labelling of asthma, avoiding
terms such as spastic bronchitis, which may lead to better
outpatient management. It is important to consider that
in these comparisons, we are considering children who
had a previous diagnosis of asthma and who were then
possibly better managed, which makes interpretation of
this part of the analysis difficult, explaining some of the in-
consistency. In addition to this, the health care systems
themselves may have a role in the diagnostic policies and
management following a diagnosis, adding an extra layer
of complexity to the interpretation of results comparing
children with a previous diagnosis of asthma.
The current study has several strengths and limitations.
First, this was a cross-sectional study, which limits our abil-
ity to investigate associations between risk factors and
asthma. However, cross-sectional studies are ideally suited
for the assessment of the prevalence of disease, which was
a major focus of our study. The response rate was excellent
in each region making reported prevalence representative
of these populations, although not of the entire countries
involved. A high response rate is necessary to complete
studies of asthma prevalence. The sample size in each re-
gion was also high reducing the likelihood of low statistical
power and Type II error. While we could not assess the
temporality of the associations investigated, we used identi-
cal questionnaires and protocols in each of the regions
while completing the study at the same point in time. In
addition to this, our study allows us to consider the associa-
tions in a consistent manner between locations so that in
the event of bias, it will be consistent across study locations.
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Asthma diagnosis lacks on objective gold standard and
questionnaire report of a doctor’s diagnosis of asthma is
used very frequently in epidemiological studies. This
method has reasonable levels of agreement with other
methods of assessment and has been suggested as the
method of choice for large epidemiologic studies [19]
given its validity and practical application. Third, this
study was based on self-report and used a proxy reporter.
This may result in some misclassification. However, previ-
ously, the sensitivity and specificity of this method to as-
sess asthma has been high compared to blinded physician
assessment [20]. Also, respiratory symptoms have been
found to be accurately reported by the adolescent and
strongly agree with parental reports in terms of asthma
diagnoses [21]. Another possibility is that the participant
experienced respiratory symptoms and did not seek med-
ical attention. However, we examined differences in preva-
lence of symptoms in addition to diagnosed conditions,
which should minimize biases due to labeling. Within
Poland, an area included in the current study, we previ-
ously found high agreement between survey reported
asthma and clinical evaluation of asthma among those
children where asthma was already reported suggesting
that asthma diagnosis is relatively accurate when applied
but that among those without a label of asthma but with
respiratory symptoms in the past year, there may be sub-
stantial underdiagnosis of asthma [22]. Additionally, lan-
guage barriers may bias the study results. Efforts were
made to ensure accurate translation by European mem-
bers of the study team who each speak multiple languages,
including those included in the study regions. Part of our
analysis considered rural vs. urban comparisons. It is pos-
sible that the design we used did not truly capture the in-
dividual’s exposure based on rural settings. For example, if
an urban dweller frequently visited a farm or had farm
type exposures in town. There are many methods of defin-
ing rural [23] and we chose to use one that would capture
exposures based on agricultural activity. Finally, potential
confounding factors that were not addressed in the
current analysis are the management practices and health
care systems in each of the countries considered. The type
and frequency of medication use may be dependent on
differences in the healthcare system and asthma medica-
tion reimbursement procedures. According to our know-
ledge, in Ukraine, Belarus and Poland, children’s health
care is free with open access to physicians. Also a high
proportion of asthma medication is reimbursed. These
problems are beyond the current publication and deserve
a more detailed and separate analysis.
Future work in this area will include further investigation
of diagnostic labeling and presenting patterns in the region.
As part of this, work must be completed to assess and im-
plement practice guidelines for the diagnosis and manage-
ment of childhood asthma. This would include education
and awareness programs aimed physicians and health care
professionals as well as the general population. Results
from Poland showing increases in asthma prevalence over
a 21 year span [6] may serve as an example of changes that
can occur after implementation of guidelines. While we
were unable to directly link individual results with imple-
mentation of asthma consensus guidelines within coun-
tries, the timing allows us some interpretation linking the
increases in asthma prevalence and improved asthma man-
agement Over this time, the proportion of those with
asthma who were treated also improved [6] suggesting that
these improvements could occur.
Conclusion
In conclusion, we found that there was significant variation
in asthma prevalence between the three BUPAS countries
and that some of this variation is likely due to diagnostic
differences between centres. By understanding patterns of
geographic variation in asthma prevalence, we will be in a
better position to study the etiology and better plan for
asthma management.
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